Exact Mass: 511.4376

Exact Mass Matches: 511.4376

Found 147 metabolites which its exact mass value is equals to given mass value 511.4376, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

17-Methyltricosanoylcarnitine

3-[(17-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


17-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 17-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 17-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 17-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

13-Methyltricosanoylcarnitine

3-[(13-Methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C31H61NO4 (511.46)


13-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 13-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 13-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 13-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methyltricosanoylcarnitine

3-[(5-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


5-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 5-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

20-Methyltricosanoylcarnitine

3-[(20-Methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C31H61NO4 (511.46)


20-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 20-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 20-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 20-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

15-Methyltricosanoylcarnitine

3-[(15-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


15-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 15-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 15-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 15-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

22-Methyltricosanoylcarnitine

3-[(22-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


22-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 22-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 22-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 22-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

11-Methyltricosanoylcarnitine

3-[(11-Methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C31H61NO4 (511.46)


11-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 11-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 11-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 11-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Methyltricosanoylcarnitine

3-[(9-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


9-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 9-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 9-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methyltricosanoylcarnitine

3-[(3-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


3-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 3-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

12-Methyltricosanoylcarnitine

3-[(12-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


12-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 12-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 12-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 12-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Methyltricosanoylcarnitine

3-[(8-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


8-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 8-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 8-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

19-Methyltricosanoylcarnitine

3-[(19-Methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C31H61NO4 (511.46)


19-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 19-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 19-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 19-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Methyltricosanoylcarnitine

3-[(6-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


6-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 6-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 6-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-Methyltricosanoylcarnitine

3-[(10-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


10-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 10-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 10-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 10-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Methyltricosanoylcarnitine

3-[(7-Methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C31H61NO4 (511.46)


7-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 7-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 7-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

18-Methyltricosanoylcarnitine

3-[(18-Methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C31H61NO4 (511.46)


18-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 18-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 18-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 18-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

16-Methyltricosanoylcarnitine

3-[(16-Methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C31H61NO4 (511.46)


16-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 16-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 16-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 16-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

14-Methyltricosanoylcarnitine

3-[(14-Methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C31H61NO4 (511.46)


14-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 14-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 14-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 14-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Methyltricosanoylcarnitine

3-[(4-methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C31H61NO4 (511.46)


4-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 4-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

21-Methyltricosanoylcarnitine

3-[(21-Methyltricosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C31H61NO4 (511.46)


21-Methyltricosanoylcarnitine is an acylcarnitine. More specifically, it is an 21-methyltricosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 21-Methyltricosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 21-Methyltricosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Stellettazole B

Stellettazole B

C30H51N6O (511.4124)


   
   
   

bis(2-hydroxypropyl)methyl(octadecyl)ammonium methyl sulphate

bis(2-hydroxypropyl)methyl(octadecyl)ammonium methyl sulphate

C26H57NO6S (511.3906)


   
   

ethylbis(hydroxyethyl)(octadecyl)ammonium ethyl sulphate

ethylbis(hydroxyethyl)(octadecyl)ammonium ethyl sulphate

C26H57NO6S (511.3906)


   

Tetracosanoyl-carnitine

Tetracosanoyl-carnitine

C31H61NO4 (511.46)


   

5-Methyltricosanoylcarnitine

5-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

9-Methyltricosanoylcarnitine

9-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

3-Methyltricosanoylcarnitine

3-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

8-Methyltricosanoylcarnitine

8-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

6-Methyltricosanoylcarnitine

6-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

7-Methyltricosanoylcarnitine

7-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

4-Methyltricosanoylcarnitine

4-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

17-Methyltricosanoylcarnitine

17-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

13-Methyltricosanoylcarnitine

13-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

20-Methyltricosanoylcarnitine

20-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

15-Methyltricosanoylcarnitine

15-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

22-Methyltricosanoylcarnitine

22-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

11-Methyltricosanoylcarnitine

11-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

12-Methyltricosanoylcarnitine

12-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

19-Methyltricosanoylcarnitine

19-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

10-Methyltricosanoylcarnitine

10-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

18-Methyltricosanoylcarnitine

18-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

16-Methyltricosanoylcarnitine

16-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

14-Methyltricosanoylcarnitine

14-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

21-Methyltricosanoylcarnitine

21-Methyltricosanoylcarnitine

C31H61NO4 (511.46)


   

Acylcarnitine C24:0

Acylcarnitine C24:0

C31H61NO4 (511.46)


   

NAGly 15:0/13:0

NAGly 15:0/13:0

C30H57NO5 (511.4237)


   

NAGly 13:0/15:0

NAGly 13:0/15:0

C30H57NO5 (511.4237)


   

NAGly 14:0/14:0

NAGly 14:0/14:0

C30H57NO5 (511.4237)


   

NAGly 10:0/18:0

NAGly 10:0/18:0

C30H57NO5 (511.4237)


   

NAGly 16:0/12:0

NAGly 16:0/12:0

C30H57NO5 (511.4237)


   

NAGly 17:0/11:0

NAGly 17:0/11:0

C30H57NO5 (511.4237)


   

NAGly 11:0/17:0

NAGly 11:0/17:0

C30H57NO5 (511.4237)


   

NAGly 12:0/16:0

NAGly 12:0/16:0

C30H57NO5 (511.4237)


   

NAGly 18:0/10:0

NAGly 18:0/10:0

C30H57NO5 (511.4237)


   

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

C33H53NO3 (511.4025)


   

(6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]octadeca-6,9,12,15-tetraenamide

(6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]octadeca-6,9,12,15-tetraenamide

C33H53NO3 (511.4025)


   

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1,3-dihydroxyundec-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide

C33H53NO3 (511.4025)


   

(4Z,7Z,10Z,13Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]hexadeca-4,7,10,13-tetraenamide

C33H53NO3 (511.4025)


   

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide

C33H53NO3 (511.4025)


   

(5Z,8Z,11Z,14Z,17Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]icosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]icosa-5,8,11,14,17-pentaenamide

C33H53NO3 (511.4025)


   

Cer 8:0;3O/22:2;(2OH)

Cer 8:0;3O/22:2;(2OH)

C30H57NO5 (511.4237)


   

Cer 12:0;3O/18:2;(2OH)

Cer 12:0;3O/18:2;(2OH)

C30H57NO5 (511.4237)


   

Cer 10:0;3O/20:2;(2OH)

Cer 10:0;3O/20:2;(2OH)

C30H57NO5 (511.4237)


   

Cer 12:1;3O/18:1;(2OH)

Cer 12:1;3O/18:1;(2OH)

C30H57NO5 (511.4237)


   

N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]hexadecanamide

N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]hexadecanamide

C31H61NO4 (511.46)


   

N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]pentadecanamide

N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]pentadecanamide

C31H61NO4 (511.46)


   

(Z)-N-(1,3,4-trihydroxypentadecan-2-yl)hexadec-7-enamide

(Z)-N-(1,3,4-trihydroxypentadecan-2-yl)hexadec-7-enamide

C31H61NO4 (511.46)


   

(Z)-N-(1,3,4-trihydroxyhexadecan-2-yl)pentadec-9-enamide

(Z)-N-(1,3,4-trihydroxyhexadecan-2-yl)pentadec-9-enamide

C31H61NO4 (511.46)


   

N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]tridecanamide

N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]tridecanamide

C31H61NO4 (511.46)


   

N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]tetradecanamide

N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]tetradecanamide

C31H61NO4 (511.46)


   

N-[(E)-1,3,4-trihydroxynonadec-8-en-2-yl]dodecanamide

N-[(E)-1,3,4-trihydroxynonadec-8-en-2-yl]dodecanamide

C31H61NO4 (511.46)


   

(Z)-N-(1,3,4-trihydroxynonadecan-2-yl)dodec-5-enamide

(Z)-N-(1,3,4-trihydroxynonadecan-2-yl)dodec-5-enamide

C31H61NO4 (511.46)


   

(Z)-N-(1,3,4-trihydroxyheptadecan-2-yl)tetradec-9-enamide

(Z)-N-(1,3,4-trihydroxyheptadecan-2-yl)tetradec-9-enamide

C31H61NO4 (511.46)


   

(Z)-N-(1,3,4-trihydroxyoctadecan-2-yl)tridec-8-enamide

(Z)-N-(1,3,4-trihydroxyoctadecan-2-yl)tridec-8-enamide

C31H61NO4 (511.46)


   

N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]heptadecanamide

N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]heptadecanamide

C31H61NO4 (511.46)


   

Cer 18:1;3O/12:1;(2OH)

Cer 18:1;3O/12:1;(2OH)

C30H57NO5 (511.4237)


   

Cer 17:1;2O/14:0;(2OH)

Cer 17:1;2O/14:0;(2OH)

C31H61NO4 (511.46)


   

Cer 14:1;3O/16:1;(2OH)

Cer 14:1;3O/16:1;(2OH)

C30H57NO5 (511.4237)


   

Cer 15:1;2O/16:0;(3OH)

Cer 15:1;2O/16:0;(3OH)

C31H61NO4 (511.46)


   

Cer 16:1;3O/14:1;(2OH)

Cer 16:1;3O/14:1;(2OH)

C30H57NO5 (511.4237)


   

Cer 16:0;2O/15:1;(2OH)

Cer 16:0;2O/15:1;(2OH)

C31H61NO4 (511.46)


   

Cer 19:0;2O/12:1;(2OH)

Cer 19:0;2O/12:1;(2OH)

C31H61NO4 (511.46)


   

Cer 18:2;3O/12:0;(2OH)

Cer 18:2;3O/12:0;(2OH)

C30H57NO5 (511.4237)


   

Cer 19:1;2O/12:0;(2OH)

Cer 19:1;2O/12:0;(2OH)

C31H61NO4 (511.46)


   

Cer 17:1;3O/13:1;(2OH)

Cer 17:1;3O/13:1;(2OH)

C30H57NO5 (511.4237)


   

Cer 17:0;2O/14:1;(2OH)

Cer 17:0;2O/14:1;(2OH)

C31H61NO4 (511.46)


   

Cer 17:0;2O/14:1;(3OH)

Cer 17:0;2O/14:1;(3OH)

C31H61NO4 (511.46)


   

Cer 16:0;2O/15:1;(3OH)

Cer 16:0;2O/15:1;(3OH)

C31H61NO4 (511.46)


   

Cer 16:1;2O/15:0;(2OH)

Cer 16:1;2O/15:0;(2OH)

C31H61NO4 (511.46)


   

Cer 15:0;2O/16:1;(3OH)

Cer 15:0;2O/16:1;(3OH)

C31H61NO4 (511.46)


   

Cer 18:1;2O/13:0;(3OH)

Cer 18:1;2O/13:0;(3OH)

C31H61NO4 (511.46)


   

Cer 14:0;3O/16:2;(2OH)

Cer 14:0;3O/16:2;(2OH)

C30H57NO5 (511.4237)


   

Cer 14:2;3O/16:0;(2OH)

Cer 14:2;3O/16:0;(2OH)

C30H57NO5 (511.4237)


   

Cer 15:0;2O/16:1;(2OH)

Cer 15:0;2O/16:1;(2OH)

C31H61NO4 (511.46)


   

Cer 15:1;3O/15:1;(2OH)

Cer 15:1;3O/15:1;(2OH)

C30H57NO5 (511.4237)


   

Cer 14:1;2O/17:0;(2OH)

Cer 14:1;2O/17:0;(2OH)

C31H61NO4 (511.46)


   

Cer 15:1;2O/16:0;(2OH)

Cer 15:1;2O/16:0;(2OH)

C31H61NO4 (511.46)


   

Cer 14:1;2O/17:0;(3OH)

Cer 14:1;2O/17:0;(3OH)

C31H61NO4 (511.46)


   

Cer 19:1;2O/12:0;(3OH)

Cer 19:1;2O/12:0;(3OH)

C31H61NO4 (511.46)


   

Cer 17:1;2O/14:0;(3OH)

Cer 17:1;2O/14:0;(3OH)

C31H61NO4 (511.46)


   

Cer 18:0;2O/13:1;(2OH)

Cer 18:0;2O/13:1;(2OH)

C31H61NO4 (511.46)


   

Cer 16:1;2O/15:0;(3OH)

Cer 16:1;2O/15:0;(3OH)

C31H61NO4 (511.46)


   

Cer 19:0;2O/12:1;(3OH)

Cer 19:0;2O/12:1;(3OH)

C31H61NO4 (511.46)


   

Cer 17:2;3O/13:0;(2OH)

Cer 17:2;3O/13:0;(2OH)

C30H57NO5 (511.4237)


   

Cer 15:2;3O/15:0;(2OH)

Cer 15:2;3O/15:0;(2OH)

C30H57NO5 (511.4237)


   

Cer 16:2;3O/14:0;(2OH)

Cer 16:2;3O/14:0;(2OH)

C30H57NO5 (511.4237)


   

Cer 18:1;2O/13:0;(2OH)

Cer 18:1;2O/13:0;(2OH)

C31H61NO4 (511.46)


   

Cer 18:0;2O/13:1;(3OH)

Cer 18:0;2O/13:1;(3OH)

C31H61NO4 (511.46)


   

AcCa(24:0)

AcCa(24:0)

C31H61NO4 (511.46)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   

Cer 14:1;O2/17:0;2OH

Cer 14:1;O2/17:0;2OH

C31H61NO4 (511.46)


   

Cer 14:1;O2/17:0;3OH

Cer 14:1;O2/17:0;3OH

C31H61NO4 (511.46)


   

Cer 14:1;O2/17:0;O

Cer 14:1;O2/17:0;O

C31H61NO4 (511.46)


   

Cer 15:1;O2/16:0;2OH

Cer 15:1;O2/16:0;2OH

C31H61NO4 (511.46)


   

Cer 15:1;O2/16:0;3OH

Cer 15:1;O2/16:0;3OH

C31H61NO4 (511.46)


   

Cer 15:1;O2/16:0;O

Cer 15:1;O2/16:0;O

C31H61NO4 (511.46)


   

Cer 16:1;O2/15:0;2OH

Cer 16:1;O2/15:0;2OH

C31H61NO4 (511.46)


   

Cer 16:1;O2/15:0;3OH

Cer 16:1;O2/15:0;3OH

C31H61NO4 (511.46)


   

Cer 16:1;O2/15:0;O

Cer 16:1;O2/15:0;O

C31H61NO4 (511.46)


   

Cer 17:1;O2/14:0;2OH

Cer 17:1;O2/14:0;2OH

C31H61NO4 (511.46)


   

Cer 17:1;O2/14:0;3OH

Cer 17:1;O2/14:0;3OH

C31H61NO4 (511.46)


   

Cer 17:1;O2/14:0;O

Cer 17:1;O2/14:0;O

C31H61NO4 (511.46)


   

Cer 18:1;O2/13:0;2OH

Cer 18:1;O2/13:0;2OH

C31H61NO4 (511.46)


   

Cer 18:1;O2/13:0;3OH

Cer 18:1;O2/13:0;3OH

C31H61NO4 (511.46)


   

Cer 18:1;O2/13:0;O

Cer 18:1;O2/13:0;O

C31H61NO4 (511.46)


   

Cer 19:1;O2/12:0;2OH

Cer 19:1;O2/12:0;2OH

C31H61NO4 (511.46)


   

Cer 19:1;O2/12:0;3OH

Cer 19:1;O2/12:0;3OH

C31H61NO4 (511.46)


   

Cer 19:1;O2/12:0;O

Cer 19:1;O2/12:0;O

C31H61NO4 (511.46)


   

Cer 20:1;O2/11:0;2OH

Cer 20:1;O2/11:0;2OH

C31H61NO4 (511.46)


   

Cer 20:1;O2/11:0;3OH

Cer 20:1;O2/11:0;3OH

C31H61NO4 (511.46)


   

Cer 20:1;O2/11:0;O

Cer 20:1;O2/11:0;O

C31H61NO4 (511.46)


   

Cer 21:1;O2/10:0;2OH

Cer 21:1;O2/10:0;2OH

C31H61NO4 (511.46)


   

Cer 21:1;O2/10:0;3OH

Cer 21:1;O2/10:0;3OH

C31H61NO4 (511.46)


   

Cer 21:1;O2/10:0;O

Cer 21:1;O2/10:0;O

C31H61NO4 (511.46)


   

Cer 14:0;O3/17:1

Cer 14:0;O3/17:1

C31H61NO4 (511.46)


   

Cer 15:0;O3/16:1

Cer 15:0;O3/16:1

C31H61NO4 (511.46)


   

Cer 16:0;O3/15:1

Cer 16:0;O3/15:1

C31H61NO4 (511.46)


   

Cer 17:0;O3/14:1

Cer 17:0;O3/14:1

C31H61NO4 (511.46)


   

Cer 31:1;O3

Cer 31:1;O3

C31H61NO4 (511.46)


   

1-(3-carbamimidamidopropyl)-4-(2-{[(2e,6e,10e)-1-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-ylidene]amino}ethyl)-3-methyl-2h-imidazol-2-yl

1-(3-carbamimidamidopropyl)-4-(2-{[(2e,6e,10e)-1-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-ylidene]amino}ethyl)-3-methyl-2h-imidazol-2-yl

C30H51N6O (511.4124)


   

n-[n-(4-{n'-[4-(n'-{4-[n'-(4-aminobutyl)carbamimidamido]butyl}carbamimidamido)butyl]carbamimidamido}butyl)carbamimidoyl]ethanimidic acid

n-[n-(4-{n'-[4-(n'-{4-[n'-(4-aminobutyl)carbamimidamido]butyl}carbamimidamido)butyl]carbamimidamido}butyl)carbamimidoyl]ethanimidic acid

C22H49N13O (511.4183)